| Name | Title | Contact Details |
|---|
LifeStation is a Union, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Paws Inc. is a Albany, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Accretive Health utilizes over a decade of operational expertise to bring measured impact to healthcare providers. We partner with hospitals and health systems to implement proprietary methodologies and relieve administrative burdens, allowing them to focus on their core mission: delivering high-quality care. Accretive Health’s operational framework centers on demonstrated capabilities and proficiencies across the end-to-end revenue cycle. Our solutions translate proven tactics and processes into measurable impact, leading to superior financial and organizational outcomes. Accretive Health utilizes over a decade of operational expertise to bring measured impact to healthcare providers. We partner with hospitals and health systems to implement proprietary methodologies and relieve administrative burdens, allowing them to focus on their core mission: delivering high-quality care. Accretive Health’s operational framework centers on demonstrated capabilities and proficiencies across the end-to-end revenue cycle. Our solutions translate proven tactics and processes into measurable impact, leading to superior financial and organizational outcomes.
Cardiva Medical, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Sunnyvale, CA. To find more information about Cardiva Medical, Inc., please visit www.cardivamedical.com
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.